Skip to content

PMCF study to quantify seal efficiency of the hyghtec® basic-plus fecal drainage

PMCF study to quantify seal efficiency of the hyghtec® basic-plus fecal drainage - HYDRA-PMCF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029594
Enrollment
40
Registered
2022-07-14
Start date
2022-08-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The products are for patients over the age of 18 who are critically ill and in intensive care, immobile or immobilised patients and/or in some cases mobile patients with persistent diarrhea.

Interventions

Group 1: The mentioned parameters of the observation are documented within a CRF.

Sponsors

Advanced Medical Balloons GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Indication for an IFMS: drainage of liquid or semi-liquid stool 2. Age = 18 years 3. Patient is expected to remain with IFMS treatment for a minimum of 48 h 4. Written informed consent 5. Insertion of the drainage possible

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity of patient to IFMS product components (polyvinyl chloride, polyurethane, silicone, polycarbonate) 2. Anatomical contraindications for IFMS use (severe rectal/anal strictures, or tumors of unclear origin) 3. Medical contraindications for IFMS use (rectal/anal bleeding, rectal/anal injuries, diseases of the rectal mucosa (i.e., proctitis, ischemic proctitis, mucosal macerations), no/insufficient tone of the anal sphincter, a gaping/open sphincter, colorectal surgery within the last 6 months) 4. Participation in another (non)interventional study or observation period of a competing study 5. Staying in a facility due to a legal or official order

Design outcomes

Primary

MeasureTime frame
Recording of the sealing efficiency based on the nursing shift using a predefined range.

Secondary

MeasureTime frame
Daily assessment of anal lesions. Daily assessment of the perianal skin status.

Countries

Germany

Contacts

Public ContactTobias Gutting

Universitätsklinikum Heidelberg Innere Medizin IV

tobias.gutting@med.uni-heidelberg.de06221 56-37985

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026